I am not surprised by the AOAC test results reported in Pfaffenroth and coworkers' letter. After use, most disinfectants become diluted because wet equipment is immersed in the solution. T h e Environmental Protection Agency which must approve manufacturers' claims does not take this "real 358 world" variable into account in their testing procedure (for further EPA disinfectant problems see Groschel's editorial, Infection Control, May/June 1983). We emphasized in our paper by way of a special note (p. 243) that routine microbiological monitoring of liquid chemical disinfected respiratory t h e r a p y e q u i p m e n t was r e c o mmended by the Centers for Disease Control. I am a little disturbed by Pfaffenroth and co-workers' finding that r o u t i n e m o n i t o r i n g showed efficacy at 30 days but AOAC tests showed only 36/60. Such data should be submitted for publication; if for no other reason than to stress the far from perfect methods we have available to evaluate disinfectants.
Timothy R. Townsend, MD
Johns Hopkins Hospital Baltimore, Maryland
Use of Multidose Vials
To the Editor:
We have received conflicting information regarding the use of multidose vials and have been unable to obtain authoritative sources of information. The question is how long can the contents be considered safe for injection once the diaphragm of the vial has been punctured? Some sources state 30 days from the first puncture and others state until the expiration date for the contents of the vial.
Sharon M. Howard, RN
Director of Nursing Ross Care Center Merrillville, Indiana
The preceding letter was referred to Mark Eggleston, PharmD, and John P. Burke, MD, for their replies.
Presently, t h e r e are conflicting results reported in the literature. Multiple dose vials (MDVs) for parenteral use a r e p o t e n t i a l l y a s o u r c e of nosocomial infections. Similar parenteral products (improperly used IV catheters, contaminated single use IV fluids) have been implicated in sporadic as well as epidemic cases of bacteremia. v Borghaus et al 9 reported that if an MDV is contaminated with a particular agent that is resistant to the bac-± teriostatic a g e n t p r e s e n t , it very quickly may become a potential source * of infection to p a t i e n t s . T h e s e r e s e a r c h e r s f o u n d t h a t bacteria recovered from unopened vials of the anesthetic fentanyl could be grown in the drug alone and in the preservative, parahydroxybenzoic acid. The generation time was less than four hours.
In contrast, a study conducted at • the National Naval Medical Center examined 1,223 samples from 864 vials which had been in use from 1 to 402 days. They could find no contamination in any MDV, and conv eluded that MDVs may safely be used until empty or until the manufacturer's expiration date, whichever occurs first. 10 Bawden et al 11 examined MDVs after collection from hospital nursing u u n i t s a n d after d e l i b e r a t e contamination. Bacteria were isolated A from d e l i b e r a t e l y c o n t a m i n a t e d MDVs when inoculated with 1 to 100 colony forming units/ml or greater when the sample was tested within one hour after contamination. Only one ] vial was positive at 16 hours and none were positive beyond that time. No bacterial contamination was found in the MDVs collected from the nursing stations. The researchers concluded that the contamination rate was probably less than 4 per 1,000.
Although the actual rate and prevalence of contaminated MDVs cannot be determined, several factors should be considered when making recommendations for discarding opened vials: 1) intrinsic contamination of unopened vials-each vial should be inspected for cracks, defective seals, or turbidity before use; 2) frequency and t e c h n i q u e with which MDVs are entered-careful aseptic technique should be followed each time the MDV is used. Vials that are so entered a n d especially t h o s e c o n t a i n i n g expensive medications used frequently in a specific location can probably be used entirely.
MDVs that are carelessly punctured and not reused for an indefinite period should be discarded, eg, some emergency room MDVs or MDVs on cardiac resuscitation carts; 3) location of M D V s -o p e r a t i n g rooms and intensive care units have patients who are considerably more vulnerable to nosocomial bacteremia; therefore, MDVs in these areas should be discarded relatively soon after initial use, thus reducing the potential for contamination; and 4) the activity of the bacteriostatic agent against various bacteria-a study by Young et al 7 showed that growth and replication of certain bacteria is unlikely when they are in prolonged contact with adequate and active bacteriostatic agents found in MDVs.
The final recommendation for control measures is still a matter of judgment. As with other infection control problems, the cost, feasibility, and eventual effectiveness of the measure must be weighed against the benefits to be derived from it.
